Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1958.16 | 1445 / 1445 | 100% | 18.31 | 183 / 183 |
breast | 100% | 2203.66 | 459 / 459 | 100% | 21.85 | 1117 / 1118 |
prostate | 100% | 2139.18 | 245 / 245 | 100% | 20.65 | 501 / 502 |
brain | 100% | 1748.89 | 2636 / 2642 | 100% | 20.86 | 705 / 705 |
lung | 100% | 1890.65 | 576 / 578 | 100% | 18.55 | 1155 / 1155 |
ovary | 100% | 2277.70 | 180 / 180 | 100% | 12.61 | 428 / 430 |
thymus | 100% | 2475.80 | 653 / 653 | 100% | 19.09 | 602 / 605 |
pancreas | 100% | 1216.19 | 328 / 328 | 99% | 14.34 | 177 / 178 |
uterus | 100% | 2519.59 | 170 / 170 | 99% | 14.44 | 455 / 459 |
kidney | 100% | 2002.52 | 89 / 89 | 99% | 18.53 | 892 / 901 |
bladder | 100% | 2111.62 | 21 / 21 | 99% | 14.90 | 498 / 504 |
stomach | 100% | 1611.75 | 359 / 359 | 98% | 15.03 | 279 / 286 |
liver | 100% | 1412.65 | 226 / 226 | 97% | 10.10 | 395 / 406 |
intestine | 100% | 2176.27 | 966 / 966 | 97% | 13.89 | 511 / 527 |
adrenal gland | 100% | 2415.22 | 258 / 258 | 96% | 12.59 | 220 / 230 |
skin | 100% | 2330.55 | 1808 / 1809 | 90% | 13.74 | 426 / 472 |
adipose | 100% | 2120.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1915.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.45 | 29 / 29 |
muscle | 100% | 5128.45 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2041.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.71 | 1 / 1 |
heart | 99% | 1634.30 | 850 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 8.34 | 58 / 80 |
peripheral blood | 52% | 842.19 | 482 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0038128 | Biological process | ERBB2 signaling pathway |
GO_0016567 | Biological process | protein ubiquitination |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0031466 | Cellular component | Cul5-RING ubiquitin ligase complex |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | CUL5 |
Protein name | CUL5 (Cullin-5) Cullin 5 Cullin-5 Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1) |
Synonyms | VACM1 |
Description | FUNCTION: Core component of multiple SCF-like ECS (Elongin-Cullin 2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination and subsequent proteasomal degradation of target proteins . As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme . The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition component . ECS(SOCS1) seems to direct ubiquitination of JAK2 . ECS(KLHDC1) complex is part of the DesCEND (destruction via C-end degrons) pathway and mediates ubiquitination and degradation of truncated SELENOS selenoprotein produced by failed UGA/Sec decoding, which ends with a glycine . As part of a multisubunit complex composed of elongin BC complex (ELOB and ELOC), elongin A/ELOA, RBX1 and CUL5; polyubiquitinates monoubiquitinated POLR2A . May form a cell surface vasopressin receptor . .; FUNCTION: (Microbial infection) Seems to be involved in proteasomal degradation of p53/TP53 stimulated by adenovirus E1B-55 kDa protein. . |
Accessions | Q93034 ENST00000393094.7 E9PP19 H0YCA0 ENST00000531427.5 ENST00000532064.5 L0L6D8 ENST00000532782.1 L0L6C1 |